Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
PRAX
PRAX News & Events
-
Add to Watchlist
Trade PRAX Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
PRAX News
Wedbush Lowers Praxis Price Target to $162 After POWER1 Miss
Jun 04 2026
NASDAQ.COM
US Stocks Close at All-Time Highs as AI Investments Surge
Jun 02 2026
NASDAQ.COM
US Stocks Rise Slightly, Tech Stocks Show Strong Rebound
Jun 02 2026
NASDAQ.COM
US Stocks Dip Slightly Amid Tech Sector Pressure
Jun 02 2026
NASDAQ.COM
Praxis Precision Medicines Reports POWER1 Study Failure
Jun 02 2026
seekingalpha
Praxis Precision Medicines Reports POWER1 Study Results for Vormatrigine
Jun 02 2026
NASDAQ.COM
Praxis Pauses Vormatrigine Study Amid Trial Setbacks
Jun 02 2026
stocktwits
POWER1 Study Results Fail to Meet Primary Success Measure
Jun 01 2026
Newsfilter
Show More News
PRAX Events
06/02 12:10
Praxis Precision Shares Drop 15.4% to $283.47
Praxis Precision is down -15.4%, or -$51.69 to $283.47.
Show More Events
PRAX Monitor News
Praxis Precision Medicines Inc rises on technical breakout
Jun 12 2026
Praxis Precision Medicines Faces Setbacks After POWER1 Study Results
Jun 05 2026
Praxis Precision Medicines Reports POWER1 Study Results
Jun 02 2026
Praxis Precision Medicines reaches 5-day high amid market gains
May 21 2026
Praxis Receives FDA Review Acceptance for Ulixacaltamide NDA
Apr 17 2026
Praxis Receives FDA Review Acceptance for Ulixacaltamide NDA
Apr 16 2026
Praxis Receives FDA Review Acceptance for Ulixacaltamide NDA
Apr 14 2026
Praxis Receives FDA Priority Review for Relutrigine
Mar 31 2026
Show More Monitor News
PRAX Earnings Analysis
No Data
People Also Watch
